Post Profile






'Twinkling' enzymes could light the way to better cancer drugs

A new test to show the properties of biologically important enzymes could help to streamline development of new treatments.
read more

share

Related Posts


FDA approves Pfizer's drug for rare blood cancer

Health : Reuters: Health

(Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it approved Pfizer Inc's treatment for a rare type of blood cancer.

FDA expands use of AstraZeneca/Merck ovarian cancer drug

Health : Reuters: Health

(Reuters) - The U.S. Food and Drug Administration on Thursday expanded the use of Lynparza, sold by AstraZeneca Plc and Merck & Co Inc, to include ongoing treatment of patients with recurrent ovarian cancer who have responded to pla...

Normal Enzyme Aids a Mutant One to Fuel Blood Cancer's Growth

Health : Newswise Medical News

A normal enzyme called SYK pairs with FLT3, the most commonly mutated enzyme in acute myelogenous leukemia, to promote cancer growth & resistance to treatment with FLT3-blocking drugs. In mouse model, treatment with a drug combinati...

3D Enzyme Model Provides New Tool for Anti-Inflammatory Drug Development

Health : Newswise Medical News

To better understand PLA2 enzymes and help drive therapeutic drug development, researchers at University of California, San Diego School of Medicine developed 3D computer models that show exactly how two PLA2 enzymes extract their s...

Vitamin C helps genes to kill off cells that would cause cancer

Health : New Scientist: Health

Many blood cancers are caused by mutations in the protective TET2 gene, but vitamin C may enhance drug treatments by helping to tell out-of-control cells to stop dividing

Comments


Copyright © 2016 Regator, LLC